For the quarter ending 2025-09-30, SOLV had $1,148M increase in cash & cash equivalents over the period. -$21M in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 1,266 | 90 | 137 | 31 |
| Depreciation and amortization | 121 | 122 | 129 | 150 |
| Pension and postretirement benefit expense | 17 | 17 | 15 | 4 |
| Stock-based compensation expense | 41 | 34 | 49 | 25 |
| Gain on sale of business | 1,518 | - | - | 0 |
| Purification and filtration transaction costs | -86 | - | - | - |
| Deferred income taxes | 130 | -33 | -144 | -62 |
| Accounts receivable | -51 | 21 | -6 | -29 |
| Due from related parties | -33 | 1 | -5 | -33 |
| Inventories | 57 | 45 | 32 | 33 |
| Accounts payable | 51 | 14 | 9 | 66 |
| Due to related parties | 24 | 0 | -6 | -172 |
| Accrued compensation | 38 | 48 | -95 | - |
| All other operating activities net | -35 | -56 | -44 | 148 |
| Net cash provided by operating activities | 76 | 169 | 29 | 219 |
| Purchases of property, plant and equipment | 97 | 110 | 109 | 127 |
| Proceeds from sale of business | 3,870 | - | - | 0 |
| Other net | 7 | 0 | 5 | 0 |
| Net cash provided by (used in) investing activities | 3,766 | -110 | -114 | -127 |
| Repayment of debt | 2,770 | 100 | 100 | 100 |
| Net transfers to 3m | -9 | -1 | 31 | 4 |
| Proceeds from long-term debt, net of issuance costs | 0 | 0 | 0 | 0 |
| Other net | 68 | -11 | -8 | 0 |
| Net cash used in financing activities | -2,693 | -110 | -139 | -104 |
| Effect of exchange rate changes on cash and cash equivalents | -1 | 6 | 1 | 2 |
| Net increase (decrease) in cash and cash equivalents | 1,148 | -45 | -223 | -10 |
| Cash and cash equivalents at beginning of period | 762 | - | - | 772 |
| Cash and cash equivalents at end of period | 1,642 | - | - | 762 |
Solventum Corp (SOLV)
Solventum Corp (SOLV)